Correction to “Safety and Efficacy of Adoptive Transfer of Stem Cell Memory Enriched Virus Specific T Cells against CMV and EBV”

In the current published version" 2.7.Clinical Responses and Outcomes of Off-The-Shelf VSTs Enriched with TSCM Against CMV/EBV Infection" section, the text "We presented clinical data from 10 patients in three dose groups (Table 1), with four patients receiving the first dose of 1 10 6 m -2 , three patients receiving the second dose of 2 10 6 m -2 , and three patients receiving the third dose of 5 10 6 m -2 ." is incorrect.The correct dosing regimen should be: "We presented clinical data from 10 patients in three dose groups (Table 1), with four patients receiving the first dose of 1 10 7 m -2 , three patients receiving the second dose of 2 10 7 m -2 , and three patients receiving the third dose of 5 10 7 m -2 ."We confirm that the dosing information presented in Table 1 ("Clinical information of VSTs recipients") 1 10 7 m -2 , 2 10 7 m -2 , and 5 10 7 m -2 is correct as published.